Screening TCGA data sets for somatic mutational signatures suggests that only a very low number of tumor specimens have missense mutations in the GPX3 coding region (somatic mutation rate of TCGA tumors: 0.3%; cBioPortal.org [120,121]). This evidence concerns the gene GPX3 and neoplasm.